Individuals increasingly use cadaver fat injections for cosmetic enhancement

7 articles · Updated · The Guardian · Apr 26

Clinics like Alpha Male in Manhattan report rising demand, with at least 75 alloClae procedures performed since early 2025, especially among wealthy professionals seeking minimal downtime.
The trend is partly driven by users of GLP-1 drugs, such as Ozempic, who seek to restore lost facial or body volume, and raises ethical questions about donor consent for cosmetic use.
This surge reflects broader anxieties about aging, shifting beauty standards, and the commercialization of body image, as anti-aging procedures become more common and socially accepted among younger demographics.

Is the 'Ozempic face' boom creating a market for injectable cadaver fat?

When you donate your body, could your final gift become cosmetic filler?

Does the cosmetic use of donor tissue threaten life-saving organ donations?

At $100,000 a treatment, is this the ultimate luxury in anti-aging?

Can using 'zombie filler' in the breast mask early signs of cancer?

Why is an injectable from a human body regulated less strictly than Botox?